Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
1 month ago
On Monday, Neurocrine Biosciences, Inc. (NASDAQ:NBIX) amended its agreement with Takeda Pharmaceutical Co Ltd (NYSE:TAK) to develop and commercialize …